HRMY
Harmony Biosciences Holdings, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +5.3% ·
flujo de acciones -0.8% ·
nuevas posiciones netas 0.0%
· fórmula
Fragmentación de la titularidad: más titulares, participación agregada más pequeña
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 21.01K | $831,838 | n/a | n/a |
| Q2 2026 | 111 | +5 | 37.63M | $1.37B | +12 | −8 |
| Q1 2026 | 110 | -3 | 39.20M | $1.10B | +5 | −9 |
| Q4 2025 | 114 | +1 | 39.01M | $1.46B | +2 | n/a |
| Q3 2025 | 20 | +1 | 24.69M | $680.58M | +2 | −2 |
| Q2 2025 | 17 | -1 | 23.07M | $729.13M | +1 | −2 |
| Q1 2025 | 15 | +1 | 6.74M | $223.55M | +1 | n/a |
| Q4 2024 | 14 | -1 | 7.61M | $261.77M | n/a | −1 |
| Q3 2024 | 14 | +1 | 3.56M | $142.57M | +1 | n/a |
| Q2 2024 | 13 | n/a | 3.50M | $105.70M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 6.93M | +2.8% | $190.88M | 0.0% | ▲ Add | 2 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (pasivo) | 5.10M | -0.3% | $140.48M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 3.85M | -17.9% | $106.02M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 4 | State Street Global Advisors ✦ (pasivo) | 1.65M | +1.5% | $45.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Arrowstreet Capital ✦ | 1.30M | +42.8% | $35.70M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 1.26M | +19.3% | $34.68M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 1.14M | +22.3% | $31.34M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 8 | Morgan Stanley ✦ | 847.89K | n/a | $23.37M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 9 | Goldman Sachs Group ✦ | 646.65K | n/a | $17.82M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | AQR Capital Management ✦ | 355.57K | +133.9% | $9.80M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 11 | JPMorgan Chase ✦ | 348.02K | n/a | $9.59M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 12 | Marshall Wace ✦ | 285.32K | -76.4% | $7.86M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 13 | Two Sigma Investments ✦ | 225.29K | -5.7% | $6.21M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 211.53K | Nuevo | $5.83M | 0.0% | New | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 204.51K | +598.2% | $5.64M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 192.63K | -23.9% | $5.31M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Citadel Advisors ✦ | 68.01K | Nuevo | $1.87M | 0.0% | New | 1 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 38.90K | -2.0% | $1.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 36.45K | +4.6% | $1.00M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Wellington Management ✦ | 19.27K | +22.5% | $531,136 | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Bridgewater Associates | $5.83M | 0.0% |
| Citadel Advisors | $1.87M | 0.0% |
Posición cerrada
| Point72 Asset Management | $1.07M | era 0.0% |
| Norges Bank | $351,487 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 306 tenedores, 54.70M acciones, $1.38B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 35.85K acc. · $1.54M
Officer · 800 acc. · $34,400
Officer · 1.80K acc. · $77,426
Officer · 22.95K acc. · $989,350
Officer · 1.00K acc. · $42,795
Officer · 4.50K acc. · $190,114
Officer · 5.50K acc. · $230,911
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología